Antibody Extraction pH Control for Heat Treatment Yield
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The production of recombinant antibodies in E. coli often results in low yields due to difficulties in achieving high percentage recovery during primary extraction, leading to increased time and costs in therapeutic antibody production.
Innovation Solution
Adjusting the pH of the sample to maintain it within the range of 6 to 9 prior to and during the heat treatment step in the antibody extraction process, which significantly enhances the yield of recombinant antibodies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If heat treatment is applied during antibody extraction from E. coli, then functional antibody yield is improved, but purification complexity increases
Solution Approach 1:
The patent applies heat treatment at elevated temperatures (e.g., 60-90°C) to selectively denature and precipitate host cell proteins while maintaining functional antibody solubility. This temperature parameter change enables differentiation between functional and non-functional antibody species, improving yield without requiring complex additional purification steps
Solution Approach 2:
The heat treatment step is performed early in the purification process, before other downstream processing steps. This preliminary action pre-clears the extract of host cell proteins and aggregates, simplifying subsequent purification operations and improving overall antibody recovery
2Productivity
If multiple purification steps are used to increase antibody recovery, then product yield is improved, but production time increases
Solution Approach 1:
The patent combines heat treatment with precipitation and filtration steps into a single integrated operation. By performing heat treatment followed by immediate centrifugation or filtration, multiple functions (denaturation, separation, and purification) are achieved in one process flow, reducing overall production time while maintaining high recovery
Solution Approach 2:
The method extracts functional antibody from the complex cellular environment by selectively precipitating contaminants through heat treatment. This extraction approach isolates the desired product early in the process, avoiding the need for multiple sequential purification steps and reducing total processing time
3Manufacturing precision
If stringent purification procedures are applied to ensure antibody quality, then product purity is improved, but manufacturing cost increases
Solution Approach 1:
The patent converts the potential harm of heat-induced protein denaturation into a beneficial selective purification mechanism. Host cell proteins and non-functional antibody species are deliberately denatured and precipitated by heat, while functional antibodies remain soluble and active. This transforms a potentially damaging process into a useful purification tool, achieving high purity without expensive additional steps
Solution Approach 2:
The method uses simple, inexpensive reagents and equipment for heat treatment (heating blocks, centrifuges, filters) rather than requiring expensive specialized purification systems. The process relies on basic thermal energy and common laboratory equipment, making high-purity antibody production accessible and cost-effective
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach can increase antibody yield by up to 40%, resulting in substantial time and cost savings in the production of therapeutic antibodies, potentially eliminating the need for additional steps like homogenization and hold steps.
Implementation Method 1
heat treatment being performed at any time during the fermentation or culture, or at any stage during extraction and purification of the antibodies. At elevated temperatures, above room temperature, functional antibodies are remarkably stable, whilst many other proteins including host cell proteins and free light and heavy chain species and non-functional fragments of antibodies, form precipitates and/or aggregates which are easily separated
Data Source
AI summary
The present disclosure relates to a method for the manufacture of recombinant antibody molecules comprising culturing a host cell sample transformed with an expression vector encoding a recombinant antibody molecule; adding an extraction buffer to the sample; and subjecting the sample to a heat treatment step; wherein the pH of the sample is detected after addition of the extraction buffer, and optionally adjusted, to ensure that the pH of the sample is 6 to 9 prior to the heat treatment step.